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doi:10.1Objective: Our objective was to evaluate the safety and feasibility of intraoperative device closure of atrial
septal defects with inferior vena cava rim deficiency.
Methods: From January 2005 to December 2008, we enrolled 65 patients who had a secundum atrial septal
defect with inferior vena cava rim deficiency closure in our institution. Patients were divided into 2 groups:
35 patients in group I underwent intraoperative device closure with a right lateral minithoracotomy and 30 in
group II underwent open cardiac repair with a right lateral thoracotomy and cardiopulmonary bypass. Intraoper-
ative device closure involved a minimal intercostal incision that was performed after full evaluation of the atrial
septal defect by transthoracic echocardiography and the insertion of the device through the delivery sheath to
occlude the atrial septal defect.
Results: The procedure was successful in all patients. In group I, the diameter of the atrial septal defect ranged
from 30 to 44 mm (mean, 35.3  3.9 mm), and the size of the implanted occluder ranged from 34 to 48 mm
(mean, 40 2.1 mm). The total occlusion rate was 82.9% immediately after the operation, 97.1% at 3 months,
and 100% at 12 and 24 months of follow-up. In group II, all patients had successful closure. A follow-up period
of 12 to 24 months was obtained in both groups. During the follow-up, there was no recurrence, thrombosis, or
device failure. In our comparative studies, group II had significantly longer operative time, intensive care unit
stay, and hospital stay than group I (P<.001). The cost of group I was less than that of group II (20,450.9 840.8
RMB vs 25,884.9  701.8; P<.001).
Conclusions: Intraoperative device closure of atrial septal defects with inferior vena cava rim deficiency is a safe
and feasible technique. It has the advantages of cost savings, cosmetic results, and less trauma than surgical
closure. Early and midterm results are encouraging. (J Thorac Cardiovasc Surg 2011;141:631-6)Earn CME credits at
http://cme.ctsnetjournals.org
Secundum atrial septal defect (ASD) is one of the most
common congenital cardiac defects and accounts for ap-
proximately 6% to 10% of all congenital cardiac defects.1
In 1976 King and associates2 attempted the first transcath-
eter closure of a secundum ASD in human beings. Trans-
catheter closure with the Amplatzer septal occluder (AGA
Medical Corporation, Plymouth, Minn) has become
standard treatment for most secundum ASDs.3-5 Defects
with inferior vena cava (IVC) rim deficiency continue toe Department of Cardiovascular Surgery, Union Hospital, Fujian Medical
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Open cardiac repair with midline sternotomy and
cardiopulmonary bypass (CPB) has been considered as
the standard for the closure of this type of ASD.6 Although
surgical closure of secundum ASD with IVC rim defi-
ciency can be reliably achieved with no mortality and min-
imal morbidity,7,8 the use of CPB is still necessary and the
midline incisions result in physical and psychologic
trauma for the patients in the future. Although some
reports have confirmed that secundum ASD with IVC
rim deficiency may be an acceptable candidate for device
closure,9,10 there is no other report involving a large
number of patients until now. Furthermore, this
technique needs more advanced equipment and the costs
are much higher than surgery in the Third World
nations.11 Our approach is to use an intraoperative device
and a minimally invasive surgical technique to close this
type of ASDs, which will result in better cosmetic inci-
sions than open cardiac surgery. Moreover, the technique
is easy to learn and its cost could be acceptable in the
Third World nations. The aim of this study is to evaluate
the safety and feasibility of intraoperative device closure
of secundum ASDs with IVC rim deficiency. The initial re-
sults are encouraging.rdiovascular Surgery c Volume 141, Number 3 631
Abbreviations and Acronyms
ASD ¼ atrial septal defect
CPB ¼ cardiopulmonary bypass
IVC ¼ inferior vena cava
TEE ¼ transesophageal echocardiography
TTE ¼ transthoracic echocardiography
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DMATERIALS AND METHODS
The present study was approved by the ethics committee of our univer-
sity and adhered to the tenets of the Declaration of Helsinki. Additionally,
written informed consent was obtained from the patients.
Device
The ASD occluder was modified from the Amplatzer atrial septal oc-
cluder. It was made in Dong Guan Ke Wei Medical Apparatus Co Ltd of
China (Figure 1). The device consists of an occluder made from an alloy
of nickel and titanium, a metal sheath, a pushing rod, and a hook. The dou-
ble disc occluder has a loop on the right disc with a 100-cm thread through
the loop, facilitating its withdrawal into the 40-cm long and 8- to 10-mm
diameter sheath. The occluder was selected in accordance with the result
of the corresponding transthoracic echocardiogram (TTE), a maximum de-
fect diameter plus 4 to 6 mm. The occluder was loaded into the sheath.12
Patients
The IVC rim was classified as either adequate (>5 mm) or deficient
(5 mm).13 Those with other rim deficiency or other coexisting cardiac
anomalies were excluded from our study. From January 2005 to December
2008, we enrolled 65 patients undergoing closure of secundum ASD with
IVC rim deficiency in our institution. TTE was used to confirm the diagno-
sis in those patients and to access the circumferential margins for closure.
On the basis of the method of closure that the patients chose, the patients
were divided into 2 groups. Group I included 35 patients (15 men and 20
women) who received intraoperative device closure treatment. The patients
ranged from 19 to 44 years in age (mean  standard deviation, 29.5  7.1
years). Their weights ranged from 46 to 75 kg (58.8  7.6 kg). Group II
included 30 patients (13 men and 17 women) referred for surgical closure.
The patients ranged from 20 to 43 years in age (28.9  6.3 years). Their
weights ranged from 46 to 76 kg (58.1 7.4 kg). Therewere no differences
in gender, age, and body weight distribution in the 2 groups.FIGURE 1. The occlusion devices.
632 The Journal of Thoracic and Cardiovascular SurgRoutine examinations included a standard electrocardiogram, a chest
radiograph, and blood tests. All patients were adults. Twenty-five patients
were symptomatic between both groups; symptoms included palpitations,
shortness of breath, exercise intolerance, and insignificant chest pain. Of
all patients, 45 had mild pulmonary hypertension (assessed by TTE; pulmo-
nary artery systolic pressure, 30–45 mm Hg), and 15 patients had moderate
pulmonary hypertension (pulmonary artery systolic pressure, 45–75 mm
Hg). Twelve patients between both groups had unsuccessful percutaneous
closure. The indications for ASD closure included hemodynamically
significant shunts and/or significant chamber enlargement and/or mild to
moderate pulmonary hypertension despite medical therapy in all patients.
Protocol
In group I, the patient was given general anesthesia and then placed in
a supine position and draped for exposure of the entire chest, with the right
hemithorax elevated approximately 30. Intraoperative TTE was used to
assess the ASD, in particular, the defect size and circumferential margins
adjacent to the superior vena cava, pulmonary vein, mitral valve, and aortic
sinus14 (Figure 2). The atrial septal occluder was chosen according to the
largest diameter of the ASD, allowing for a margin of 4 to 6 mm in excess
of the diameter in patients. A right anterior submammary minithoracotomy
(about 3 cm in length) was made through the fourth intercostal space. A
small rib spreader was used in this manipulation incision to facilitate instru-
mentation. The pericardium was opened and suspended to expose the right
atrium. In the anterolateral right atrium, 2 parallel 4–0 Prolene polypropyl-
ene sutures (Ethicon, Inc, Somerville, NJ) of approximately 15 mm in
diameter were stitched, heparin was intravenously given(1 mg/kg body
weight), and the activated clotting time was monitored to be greater than
250 seconds. The occluder was drawn into the delivery sheath, and then
a 15-mm incision was opened in the right atrium and the delivery sheath
was inserted. Under continuous TTE guidance, the sheath was advanced
through the ASD into the left atrium. The left disc was deployed first by
pushing the rod. After the left disc had been adjusted to be parallel to the
atrial septum, the sheath was withdrawn, and then the right disc was de-
ployed on the other side to occlude the ASD. A to-and-fro motion of the
sheath was performed to ensure a secure position across the defect.15,16
The occluder could easily be dislodged back into the right atrium
through the deficient IVC rim, so we added some new techniques.
During the process of occluder deployment, the occluder was moved to
the rim of the superior vena cava by moving the shield as close as
possible; then the ‘‘left atrium–occluder–right atrium’’ suture was placed
through the junction of the Waterston groove and the IVC to fix theFIGURE 2. Transthoracic echocardiographic image showed the circum-
ferential margins of the ASDs with IVC rim. SVC, Superior vena cava;
IVC, inferior vena cava; ASD, atrial septal defect; IAS, interatrial septum;
LA, left atrium; RA, right atrium.
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FIGURE 3. The arrow shows the suture through the ‘‘left atrium–oc-
cluder–right atrium.’’ AO, Aorta; SVC, superior vena cava; IVC, inferior
vena cava; TV, tricuspid valve.
TABLE 1. Comparison of clinical data in both groups
Group I Group II P value
No. of patients 35 30
Male/female 15/20 13/17 >.05
Age (y) 29.5  7.1 28.9  6.3 >.05
Body weight (kg) 58.8  7.6 58.1  7.4 >.05
Operative time (min) 54.0  9.2 110.5  7.4 <.001
ICU stay (h) 9.5  2.6 17.9  3.9 <.001
Hospital stay (d) 5.6  0.8 6.4  0.7 <.001
Arrhythmia (%) 12/35 18/30 <.05
Follow-up (mo) 18.2  6.1 18.0  6.0 >.05
Total cost (RMB) 20,450.9  840.8 25,884.9  701.8 <.001
ICU, Intensive care unit; RMB, Renminbi, the Chinese currency.
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Doccluder (Figure 3). After TTE evaluation no significant residual shunt, no
atrioventricular valve distortion, and no obstruction of the coronary sinus
were detected. The thread was cut and the sheath was withdrawn with
the suture snugly tied. The chest was closed routinely with a drainage
tube in place. Oral aspirin had been taken for 3 months as an anticoagulant.
In group II, all patients had undergone attempted open cardiac repair
with a right lateral thoracotomy of 16 to 20 cm and CPB.
Statistical Analysis
Continuous data are given as mean  standard deviation and range.
Clinical parameters between the 2 groups were compared with the indepen-
dent samples t test. Nominal variables were compared between the 2 groups
using Fisher’s exact test. Arrhythmia was analyzed by the c2 test.
RESULTS
Delivery of the occluder was successful in all patients in
group I. The size of the ASD as measured by TTE ranged
from 30 to 44 mm (mean, 35.3  3.9 mm). The size of
the occluder implanted ranged from 34 to 48 mm, (mean,
40  2.1 mm) and the diameter of the sheath was 8 to 10
mm. The duration of the procedure was in 40 to 70 minutes
(mean, 54.0 9.2 minutes). The intensive care unit stay was
about 6 to 12 hours (mean, 9.5  2.6 hours), and hospital
stay was 4 to 7 days (mean, 5.6  0.8 days).
In those who had a successful attempt, the overall rate of
immediate complete closure was 82.9%. Those patients
have small residual shunts and the position of the shunt
was the junction of the occluder and the IVC. At 3 months,
1 of 35 patients still had a small residual shunt. However,
the closure rate remained 100% at 1 year’s follow-up.
In group I, minor complications were encountered in 15
patients, including transient arrhythmia in the course of
device deployment. Temporary sinus bradycardia and atrial
premature beats were observed in these patients immediately
and were easily treated by medicine or else they resolved
spontaneously. Immediate postprocedure third-degree
atrioventricular block was observed in 1 patient with an
ASD diameter of 40 mm and a occluder size of 44 mm.The Journal of Thoracic and CaBecause heart rates were about 50 to 55 beats/min, no inter-
ventionwas needed except close observation. After treatment
by glucocorticoid, the atrioventricular block resolved sponta-
neously after 1 week. Blood loss requiring transfusion
occurred in 9 early cases owing to lack of experience. There
had been no episodes of hydrothorax, endocarditis, thrombo-
embolism, device disruption or failure, or atrioventricular
valve distortion.
Total follow-up period ranged from 12 to 24 months
(18.2  6.1 months) in group I. Out-patient follow-up was
by functional echocardiographic assessment. Symptoms
had been either resolved totally or improved significantly
in all symptomatic patients. Those patients with mild to
moderate pulmonary hypertension had a significant de-
creased in hypertension as evaluated by the tricuspid regur-
gitation jet. The complete closure rate was 100% during 1
year of follow-up. No thromboembolic event or other major
complications were found during the follow-up period. The
incision in the chest wasminor and cosmetically acceptable.
In group II, all patients needed a blood transfusion. Sinus
bradycardia and atrial premature beats were observed in 18
patients, especially during the operation. Some patients re-
covered immediately, and others needed medicine treat-
ment for 3 to 5 days. During the follow-up period (18.0 
6.0 months), there were no episodes of ASD residual fistula,
hydrothorax, endocarditis, thromboembolism, or perma-
nent rhythm disturbances. The incision in the right lateral
chest wall was about 16 to 20 cm.
Table 1 demonstrates the clinical data comparison of all
patients in both groups. Group II required longer operative
time, intensive care unit stay, and hospital stay than group I
(P<.001). Thirty patients had postoperative arrhythmia,12
in group I and 18 in group II (P<.05). The average total cost
in the surgical group (25,884.9  701.8 RMB) was higher
than in the device group (20,450.9  840.8 RMB)
(P<.001).
DISCUSSION
Patients with secundum ASD are usually asymptomatic.
However, owing to poor medical resources and knowledge,rdiovascular Surgery c Volume 141, Number 3 633
FIGURE 4. The arrow show trivial or small residual shunts in the inferior
vena cava rim, which can be ignored. LA, Left atrium; RA, right atrium.
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and wait until they are adults. This phenomenon is prevalent
in low-income countries, such as China. Elective open car-
diac repair with midline sternotomy and CPB has been con-
sidered as the gold standard for the closure of ASD in such
patients. Although surgical closure of ASD has been proved
safe and effective, it is still associated with midline sternot-
omy and CPB with a longer hospital stay. With the develop-
ments of various devices, percutaneous transcatheter
occlusions of ASD have gradually become the first choice
for selected patients. For the device to be placed to close
the ASD, a rim of tissue around the defect is required. A
certain failure rate exists, especially in those with deficient
rims. Owing to the deficiency of the ASD rim, transcatheter
closure of this type of ASD is challenging and has
frequently been associated with complications such as re-
sidual shunts, subsequent malposition, and embolization
of the device. Furthermore, owing to expensive equipment
and high cost, many hospitals in low-income nations have
no resources to develop this technology. Thus, surgical
closure of ASD with IVC rim deficiency is still the first
choice for these patients. In group II, instead of a midline
sternotomy, a right anterior submammary thoracotomy
(about 16–20 cm in length) was selected, which would be
more cosmetically pleasing than the midline incision.
In group I, we applied a minimally invasive technique,
intraoperative device closure of ASD, which imitates per-
cutaneous closure of the ASD.17-21 The open-chest ap-
proach offered an operative field and allowed the cardiac
surgeons to do this technique. Because of the avoidance
of CPB, we could limit the length of the incision to between
2.5 and 3 cm. Moreover, it was easy to extend for conver-
sion to a regular open cardiac procedure if the intraopera-
tive device closure failed. The procedure time could be
significantly shortened; in our series, the skin-to-skin
time could be limited to 40 to 75 minutes. This method pro-
vides a perpendicular angle to the atrial septum, which may
result in easily deploying the occluder into the defect. A di-
lemma for a large ASD is choosing the location for the
placement of the occluding device, especially for our pa-
tients with an uneven septum. Because larger devices
may interfere with the neighboring structure, the device
size and position must be verified carefully by TTE after
deployment. During the operation, it is advisable to retract
the right disc into its sheath, then push the sheath by hand
against the IVC rim, move the occluder to the rim of the su-
perior vena cava, aortic sinus, and mitral valve, and then re-
open the right disc. The occluder can easily be dislodged
back into the right atrium through the deficient IVC rim.
Thus we suture the ‘‘left atrium–occluder–right atrium’’
through the junction of the Waterston groove and the IVC
to fix the occluder. A single stitch is enough to fix the atrial
septal occluder. Because of the smaller incision and no use
of CPB, the procedure results in less pain, quicker recovery,634 The Journal of Thoracic and Cardiovascular Surgshorter hospital stay, and a more cosmetically acceptable
incision.
Zhanjun Guan and associates22 reported a series of 18
large secundum ASDs on transcatheter closure. They
proclaimed that 3 aspects must be considered before a large
ASD transcatheter procedure: (1) accurate measurement of
the ASD size and shape, (2) choice of the occluding device
with proper diameter, and (3) accurate measurement of the
residual septum surrounding the ASD. We applied the same
criteria with cardiologists to allow us to choose ‘‘suitable’’
patients. TTE also plays a crucial role in the procedure.23-25
In addition to the deficient IVC rim, the other rims should be
sufficient. Jen-Chung Chien and coworkers26 reported that
transesophageal echocardiography (TEE) improves assess-
ment of the size, number, and position of the defects over
traditional TTE. In early some cases, we used TEE to
gain experience and then transferred TEE to simplied
TTE. In our opinion, TTE is also a reliable method in quan-
titating ASD diameters and circumferential margins. The
residual septum around the ASD can be accurately mea-
sured by TTE and the distance from the edge of the ASD
to superior vena cava, right pulmonary vein, aortic root,
atrioventricular valves, and coronary sinus can be reason-
ably obtained,27 especially the IVC rim. It has also been
useful for monitoring and guiding device-deployment
procedures.
In our series, device closurewas successful in all patients.
In those who had a successful attempt, closure rate was
82.9% immediately after the operation, 97.1% at 3 months,
and 100% at 12 months’ and 24 months’ follow-up. Trivial
or small residual shunts in the IVC rim can be ignored
immediately after the release of device inasmuch as they
usually disappear during the follow-up period (Figure 4).
This early shunt was associated with the loose links
between the occluding device and the deficient IVC rim.
Several weeks later, endothelialization will cover the
surface of the device, and neointima will form and fullyery c March 2011
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Dclose any residual shunting. Minor complications were
encountered in 15 patients, including transient arrhythmias
in the course of occluder deployment. Temporary sinus bra-
dycardia and atrial premature beats were observed in these
patients immediately, but these were easily treated by med-
icine or else they resolved spontaneously.28 If we use the
larger sized occluder, the atrial septum would be more eas-
ily deformed. Such deformity may temporarily affect the
heart conduction system. The occluder chosenmust be large
enough to close the ASD but cannot change the structure of
the cardiac geometry. If any deformation or interference of
the device had been found, the other size of device would
have been redeployed. Reducing intraoperative stimulus
was also beneficial for transient arrhythmias. In 9 early
cases, blood loss requiring transfusion occurred owing to
lack of experience. Thus it is important to prepare plenty
of blood products before the start of the operation. However,
in our past experience, the last patients of the series did not
require a transfusion. In studies involving transcatheter
closure, comparison of successful and unsuccessful deploy-
ment revealed a significant association of the deficiency of
the rim and a large defect diameter with failure of implan-
tation.9,29 In our study, we did not encounter failure in the
implantation of the device using intraoperative device
closure of ASD with IVC rim deficiency.
Relatively higher medical cost always presents a real
challenge in popularizing a percutaneous approach in
Third World nations. We chose a domestically made
device to maximally reduce the medical costs. In our study,
treating the intraoperative device group was still cheaper
than treating the surgical group. This technique did not
need an expensive x-ray machine and also could be easily
mastered. However, our study was conducted in low-
income countries, where health care resources were
limited. Given these circumstances, the cost-effective
intraoperative device closure should be the treatment of
choice to allow the ASD with IVC rim deficiency to be
effectively treated.
As in any retrospective study, there is bias associated with
data collection and the enrolling patients in the 2 groups,
which were not randomized. As a result of the 35 cases in
group I and 30 cases in group II, our experiencewas limited,
and longer follow-up is needed to determine future
research. We just speculated on its advantages according
to our experience. The group of patients selected comprised
only adults, with no small and young children being
included. In general, placement of ASD devices is more
challenging and complicated in small children. We did
not include the small and young patients with this type
ASD. This study was limited to one institution, and other
institutions may find different results. The other limitation
was that this study was conducted in a low-income country,
and there might be different cost-effectiveness results in
high-income countries.The Journal of Thoracic and CaIn conclusion, our study demonstrated that intraopera-
tive device closure of ASDs with IVC rim deficiency
was a safe and feasible alternative to surgery. It had the
advantages of cost savings, cosmetically acceptable re-
sults, and less trauma than surgical closure. Intraoperative
device closure of ASDs with IVC rim deficiency should be
recommended.References
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